Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01146704 · ClinicalTrials.gov registry record · NA
Gastrointestinal Hormonal Regulation of Obesity
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT01146704: Completed NA study, sponsored by VA Office of Research and Development.
NCT01146704 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 31 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01146704, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The objective of this study is to test and determine whether a high protein diet is efficacious, safe and beneficial to curtail food intake and body weight in obese adult human patients and to establish whether neurohormonal mechanisms of a high protein diet induce an early signal of fullness or satiety in a relevant experimental model, focusing on activation of gastric vagal afferents.
Interventions
- DIETARY_SUPPLEMENT Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass
- DIETARY_SUPPLEMENT Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2010-09-01 |
| Est. Completion | 2019-02-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01146704
The ClinicalTrials.gov registry entry for NCT01146704 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass is the first listed.
NCT01146704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01146704 about?
NCT01146704 is a clinical study titled "Gastrointestinal Hormonal Regulation of Obesity". The objective of this study is to test and determine whether a high protein diet is efficacious, safe and beneficial to curtail food intake and body weight in obese adult human patients and to establish whether neurohormonal mechanisms of a high protein diet induce an early signal of fullness or sat...
What is the current status of trial NCT01146704?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2010-09-01. Estimated completion is 2019-02-27.
What interventions are being tested in trial NCT01146704?
The interventions under investigation include: Protein powder supplement, standard dosage based on 0.5 gram protein per pound of subject's lean body mass (DIETARY_SUPPLEMENT), Protein powder supplement, High Level Protein, based on 1 gram of protein per pound of lean body mass: 25% protein and 45% carbohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01146704?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.